Bioorganic & Medicinal Chemistry Letters 2006-05-15

Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

Ester Muraglia, Olaf D Kinzel, Ralph Laufer, Michael D Miller, Gregory Moyer, Vandna Munshi, Federica Orvieto, Maria Cecilia Palumbi, Giovanna Pescatore, Michael Rowley, Peter D Williams, Vincenzo Summa

Index: Bioorg. Med. Chem. Lett. 16(10) , 2748-52, (2006)

Full Text: HTML

Abstract

A series of aryltetrazolylacetanilides was synthesized and evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors on wild-type virus and on the clinically relevant K103N mutant strain. Extensive SAR investigation led to potent compounds, with nanomolar activity on K103N, and orally bioavailable in rats.


Related Compounds

Related Articles:

The metabolism of thioacetanilide in the rat.

1983-08-01

[Xenobiotica 13(8) , 475-82, (1983)]

1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.

2009-09-01

[Bioorg. Med. Chem. 17(17) , 6374-9, (2009)]

Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

2009-08-15

[Bioorg. Med. Chem. 17(16) , 5775-81, (2009)]

Effects from filtration, capping agents, and presence/absence of food on the toxicity of silver nanoparticles to Daphnia magna.

2010-12-01

[Bioorg. Med. Chem. 20(18) , 5527-36, (2012)]

[Substantiation of maximum permissible levels of thioacylanilide in the air of work areas].

1986-07-01

[Gig. Tr. Prof. Zabol. (7) , 51-2, (1986)]

More Articles...